Home › Companies › MoonLake Immunotherapeutics
How asset managers voted at MoonLake Immunotherapeutics’s shareholder meetings, one page per proxy season, compiled from the votes funds and managers report on SEC Form N-PX and the company’s own results on Form 8-K.
| Season | Filed as | Ballot items | Asset managers |
|---|---|---|---|
| 2025-2026 | MoonLake Immunotherapeutics | 4 | 123 |
| 2024-2025 | MOONLAKE IMMUNOTHERAPEUTICS | 5 | 132 |
| 2023-2024 | MOONLAKE IMMUNOTHERAPEUTICS | 5 | 122 |
Earlier seasons list this company under the name MOONLAKE IMMUNOTHERAPEUTICS, as its holders filed it.
Explore MoonLake Immunotherapeutics in the interactive database
The seasons are grouped by the issuer number in the company’s CUSIP, not by its name. Ticker as listed by the SEC on October 13, 2026. This page is rebuilt weekly; built October 16, 2026.